MS201408-0005A

· EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MS201408-0005A, covering 2020-02-06 to 2020-02-06. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Study of MS201408-0005A as Single Agent and in Combinations [Phase 1]